Results 251 to 260 of about 650,104 (308)

Engineering a Gibberellin‐Switchable Dual‐Use Line Based on Ent‐Kaurene Oxidase Gene ZmKO1 Enables Two‐Line Hybrid Seed Production in Maize

Plant Biotechnology Journal, Volume 24, Issue 6, Page 4361-4377, June 2026.
ABSTRACT Male‐sterile systems are pivotal for maize hybrid seed production, yet existing systems are constrained by significant limitations. Here, we identified a novel single‐gene‐controlled recessive genic male sterility (GMS) mutant, defective in filament elongation 1 (def1), which exhibits non‐elongated filaments, unopened glumes, and non‐exserted ...
Chuan Li, Siyu Wang, Yong Xiang, Tao Yu, Rujun Wei, Wenqian Mei, Xiaowei Liu, Peng Yuan, Hongyang Yi, Shufeng Zhou, Chao Xia, Moju Cao, Hai Lan   +12 more
wiley   +1 more source

Exposure-safety analyses of talazoparib in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC) in the TALAPRO-2 trial. [PDF]

J Pharmacokinet Pharmacodyn
Wang Y, Hadigol M, Lincha VR, Hoffman J, Azad AA, Agarwal N, Matsubara N, Zohren F, DeAnnuntis L, Wang DD.   +9 more
europepmc   +1 more source

Comprehensive Profiling Reveals Sialyl‐Tn Upregulation and Prognostic Value in Prostate Cancer

Pathology International, Volume 76, Issue 6, June 2026.
This study utilises a novel antibody (L2A5) to comprehensively monitor sialyl‐Tn antigen (sTn) expression levels in clinical prostate cancer tissues. We reveal sTn is expressed in 44% of prostate tumours and find prostate cancer patients with high sTn levels have significantly poorer survival times.
Kirsty Hodgson, Libby Blencoe, Erin Smith, Aswini Sasikumar, Ziqian Peng, Margarita Orozco‐Moreno, Richard Beatson, Paula A. Videira, Jennifer Munkley   +8 more
wiley   +1 more source

Pembrolizumab for high TMB castration-resistant prostate cancer: A precision medicine case report. [PDF]

Int Cancer Conf J
Terrano V, Perri E, Cioffo C, Mastroianni G, Palumbo MA, Ciardiello F, Troiani T, Napolitano S.   +7 more
europepmc   +1 more source

Gender Non‐Conformity in Islamic Studies and Muslim Communities Across Times and Theoretical Frameworks

Sociology Compass, Volume 20, Issue 6, June 2026.
ABSTRACT This article examines gender diversity in Islamicate societies across historical and contemporary contexts, emphasizing the interplay between social norms, religious frameworks, and structural power. It addresses the methodological challenge of avoiding anachronistic applications of modern categories such as “gender” and “sexuality” to Muslim ...
Vanja Hamzić
wiley   +1 more source

Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis. [PDF]

Oncologist
Saxena A, Yorker M, Zorko NA, Narayan V, Siddiqui BA, Saraiya B, Tester WJ, Mille PJ, Shaver AL, Nikita N, Lu-Yao GL, Kelly WK, Zarrabi KK.   +12 more
europepmc   +1 more source

Casticin inhibits AKR1C3 and enhances abiraterone efficacy in castration-resistant prostate cancer. [PDF]

J Nat Med
Piska K, Zubek M, Bucki A, Świtalska M, Koczurkiewicz-Adamczyk P, Władyka B, Kołaczkowski M, Pękala E.   +7 more
europepmc   +1 more source

KELIM PSA as a Prognostic Biomarker in Castration-Resistant Prostate Cancer Treated with ARPI. [PDF]

J Clin Med
Atalah F, Kuş F, Acarbay A, Karakök A, Alkan O, Nazlı İ, Özilice U, Beşiroğlu M, Gümüş M.   +8 more
europepmc   +1 more source

Heterogeneity in Treatment Effects of Reduced Versus Standard Dose of Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer. [PDF]

Cancer Med
Fukuokaya W, Mori K, Yanagisawa T, Ito K, Urabe F, Rajwa P, Shariat SF, Kimura T, Hirakawa A.   +8 more
europepmc   +1 more source

Genomic landscape and clinical impact of BRCA1/2 pathogenic variants in metastatic castration-resistant prostate cancer. [PDF]

NPJ Precis Oncol
Iida K, Urabe F, Matsui Y, Tashiro K, Yoshihara K, Urabe Y, Ishikawa T, Matsuzaki J, Kimura T, Saito Y.   +9 more
europepmc   +1 more source